Chicago Business

AbbVie in 'gold rush' for treating bowel disease

AbbVie in 'gold rush' for treating bowel disease

Having trouble viewing this email? See the online version

Health Pulse Breaking News

Wednesday, June 19, 2024
Digestive system model demonstrating inflammatory bowel disease

In a 'gold rush' for treating bowel disease, AbbVie clears one more stage

A growing number of drugs are proving to bring diseases into remission, changing the prognosis for long-suffering patients, a UChicago Medicine doctor says.

 
Read More >

Did someone forward this to you? Sign up for Health Pulse breaking news alerts here and unlock access to the full story with a Health Pulse subscription.

UNLOCK YOUR ACCESS

Discover the latest insights, analysis & opinion needed to navigate Chicago's complex business landscape.

<![if !mso]> <![endif]>
VIEW OUR SUBSCRIPTION OFFERS
 

This email was sent to chicagobusinessus627@emails.newslettersbase.com
Manage My Account | Contact Us

 

© 2024 Crain Communications Inc
130 E. Randolph St., Suite 3200, Chicago, IL 60601 United States
Privacy Policy | Terms and Conditions | Unsubscribe

 
  • This email was sent

    June 19, 2024 8:38pm

  • Country:

    United States

  • Tags